Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing–remitting multiple sclerosis

Mercurio A Ruggeri S Altieri M . 2011. Rickettsial infection in a multiple sclerosis patient treated with TysabriÆ: a case report. Mult Scler J 17(10 suppl), S356-S357.

Riminton DS Hartung HP Reddel SW 2011. Managing the risks of immunosuppression. Curr Opin Neurol 24, 217–223.

Siddiqi SH Rüsch-Gerdes S. 2006. Procedure Manual for BACTEC MGIT 960 TB System, July 2006.

Pavlik I Falkinham JO III Kazda J 2009. Environments providing favourable conditions for the multiplication and transmission of mycobacteria. In: Kazda J Pavlik I Falkinham JO III Hruska K (Ed.). The Ecology of Mycobacteria: Impact on Animal’s and Human’s health. Springer Science+Business Media B.V., pp.89–198.

Kubin M. Svandova E. Medek B. Chobot S. Olsovsky Z. 1980. Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle 61(4), 207–212.